Published in EMBO J on July 01, 1992
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J (1992) 2.65
The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol (1993) 2.53
Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer (2010) 2.20
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol (1993) 2.14
RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J (1994) 2.04
Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J (2004) 1.94
Structural basis of hepatocyte growth factor/scatter factor and MET signalling. Proc Natl Acad Sci U S A (2006) 1.85
Targeting the hepatocyte growth factor-cMET axis in cancer therapy. J Clin Oncol (2012) 1.77
Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61
Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets (2012) 1.45
Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J Clin Invest (1993) 1.44
A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J Cell Biol (1997) 1.30
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci (1994) 1.29
The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology (2001) 1.27
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J Clin Invest (2004) 1.25
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. Proc Natl Acad Sci U S A (2013) 1.20
Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma. Cancer Res (2010) 1.14
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met. J Biol Chem (2008) 1.06
The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res (2010) 1.04
Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut (2003) 0.96
Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther (2009) 0.96
Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli. Biochem J (1997) 0.96
Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist. Proc Natl Acad Sci U S A (2007) 0.95
Mechanisms of hepatocyte growth factor activation in cancer tissues. Cancers (Basel) (2014) 0.94
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. PLoS One (2008) 0.90
Flexibility and small pockets at protein-protein interfaces: New insights into druggability. Prog Biophys Mol Biol (2015) 0.90
Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstem. Dev Neurosci (2013) 0.87
Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists. Proc Natl Acad Sci U S A (2011) 0.87
Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa. J Biol Chem (2002) 0.85
A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells. Mol Biol Cell (1996) 0.84
Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor. Growth Factors (2008) 0.83
Achieving high signal-to-noise in cell regulatory systems: Spatial organization of multiprotein transmembrane assemblies of FGFR and MET receptors. Prog Biophys Mol Biol (2015) 0.83
Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy? Gut (2000) 0.81
Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling. J Biol Chem (2010) 0.81
Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance. Transl Lung Cancer Res (2015) 0.80
Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet? J Cancer (2016) 0.79
The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer. Curr Signal Transduct Ther (2011) 0.79
Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6. Biosci Rep (2015) 0.79
Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent. Biochem J (2005) 0.79
Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy. Ann Clin Transl Neurol (2015) 0.78
Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling. Oncotarget (2016) 0.77
MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications. Transl Lung Cancer Res (2012) 0.76
Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet Receptor. Oncolytic Virother (2016) 0.75
Preclinical development of a humanized neutralizing antibody targeting HGF. Exp Mol Med (2017) 0.75
Probing conformational and functional states of human hepatocyte growth factor by a panel of monoclonal antibodies. Sci Rep (2016) 0.75
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration. PLoS One (2015) 0.75
Expression array analysis of the hepatocyte growth factor invasive program. Clin Exp Metastasis (2015) 0.75
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges. Nat Rev Clin Oncol (2017) 0.75
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Signal transduction by receptors with tyrosine kinase activity. Cell (1990) 22.72
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (1991) 8.68
Molecular cloning and expression of human hepatocyte growth factor. Nature (1989) 6.91
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (1987) 6.26
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell (1991) 4.98
Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol (1990) 4.05
Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci U S A (1987) 3.99
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun (1984) 3.70
Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene (1991) 3.41
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun (1989) 3.21
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93
Direct determination of the protonation states of aspartic acid-102 and histidine-57 in the tetrahedral intermediate of the serine proteases: neutron structure of trypsin. Biochemistry (1981) 2.30
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest (1988) 2.22
Control of hepatocyte replication by two serum factors. Cancer Res (1984) 2.20
Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci U S A (1990) 2.15
Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci (1989) 2.01
Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem Biophys Res Commun (1991) 1.95
Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol (1991) 1.90
Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology (1991) 1.88
Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol (1984) 1.56
Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry (1991) 1.49
Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun (1990) 1.49
Identification of a competitive HGF antagonist encoded by an alternative transcript. Science (1991) 1.44
Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun (1991) 1.42
The hormonal control of gluconeogenesis by regulation of mitochondrial pyruvate carboxylation in isolated rat liver cells. J Biol Chem (1975) 1.28
The refinement and the structure of the dimer of alpha-chymotrypsin at 1.67-A resolution. J Biol Chem (1985) 1.27
Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. Biochem Biophys Res Commun (1991) 1.20
An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur J Biochem (1991) 1.15
Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats. J Biochem (1991) 1.13
Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis. Biochemistry (1987) 1.02
Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor. Biochem Biophys Res Commun (1991) 0.92
Plasminogen activation: biochemistry, physiology, and therapeutics. Crit Rev Biotechnol (1988) 0.87
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (1999) 7.75
Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol (2001) 6.62
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature (1998) 6.49
Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell (1986) 4.66
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol (2001) 4.13
Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol (2000) 3.96
Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci U S A (1991) 3.76
Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature (1987) 3.42
Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc Natl Acad Sci U S A (1986) 3.28
Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science (1989) 3.06
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell (1980) 2.76
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science (1987) 2.33
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest (1992) 2.33
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest (1991) 2.32
Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science (1991) 2.25
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest (1992) 2.19
Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol (2000) 2.16
Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol (1991) 2.10
Characterization of two high affinity human interleukin-8 receptors. J Biol Chem (1992) 2.09
RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J (1994) 2.04
The toll of innate immunity on microbial pathogens. N Engl J Med (1999) 1.98
Mutations in the major DNA-binding protein gene of herpes simplex virus type 1 result in increased levels of viral gene expression. J Virol (1983) 1.98
Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem (1991) 1.89
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A (1997) 1.89
Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes. J Virol (1985) 1.79
Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol (2000) 1.77
Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene (1997) 1.70
Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol (1990) 1.69
Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell (1995) 1.67
Protease nexin. Properties and a modified purification procedure. J Biol Chem (1985) 1.66
Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol (1999) 1.63
Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases. Proc Natl Acad Sci U S A (1981) 1.53
Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol (1999) 1.51
Characterization of herpes simplex virus 2 temperature-sensitive mutants whose lesions map in or near the coding sequences for the major DNA-binding protein. J Virol (1983) 1.51
Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin. J Cell Biol (1988) 1.49
Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I. Proc Natl Acad Sci U S A (1986) 1.47
Genome-wide association study of growth in crossbred beef cattle. J Anim Sci (2009) 1.46
Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci (1996) 1.45
Effects of intravenous IL-8 administration in nonhuman primates. J Immunol (1992) 1.44
Bovine respiratory disease in feedlot cattle: environmental, genetic, and economic factors. J Anim Sci (2006) 1.40
Direct linkage of 125I-EGF to cell surface receptors. A useful artifact of chloramine-T treatment. J Biol Chem (1982) 1.38
In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology (1994) 1.38
Sequence evaluation of four pooled-tissue normalized bovine cDNA libraries and construction of a gene index for cattle. Genome Res (2001) 1.26
In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol (1992) 1.26
Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol (1993) 1.24
Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem (1984) 1.24
Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. J Biol Chem (1991) 1.24
Thrombin and epidermal growth factor become linked to cell surface receptors during mitogenic stimulation. Nature (1979) 1.23
Cryptic urokinase binding sites on human foreskin fibroblasts. Biochem Biophys Res Commun (1985) 1.22
A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature (1997) 1.20
Efficient computation of genotype probabilities for loci with many alleles: II. Iterative method for large, complex pedigrees. J Anim Sci (2001) 1.19
Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J Cell Biol (1996) 1.19
Association of markers in the bovine CAPN1 gene with meat tenderness in large crossbred populations that sample influential industry sires. J Anim Sci (2004) 1.18
Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture. Proc Natl Acad Sci U S A (1978) 1.15
Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci U S A (1992) 1.14
Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J Biol Chem (1995) 1.14
Modal behavior of cortical neural networks during visual processing. J Neurosci (1999) 1.12
rse, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain. J Biol Chem (1994) 1.11
Purification of human protease nexin. J Biol Chem (1983) 1.11
Cells regulate their mitogenic response to thrombin through release of protease nexin. Nature (1982) 1.10
The CT small bowel faeces sign: description and clinical significance. Clin Radiol (1995) 1.09
Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin. J Biol Chem (1983) 1.09
Evidence that a variety of cultured cells secrete protease nexin and produce a distinct cytoplasmic serine protease-binding factor. J Cell Physiol (1983) 1.09
Bovine respiratory disease in feedlot cattle: phenotypic, environmental, and genetic correlations with growth, carcass, and longissimus muscle palatability traits. J Anim Sci (2007) 1.09
Initial results of genomic scans for ovulation rate in a cattle population selected for increased twinning rate. J Anim Sci (2000) 1.08
Efficient computation of genotype probabilities for loci with many alleles: I. Allelic peeling. J Anim Sci (2001) 1.08
Partial-genome evaluation of postweaning feed intake and efficiency of crossbred beef cattle. J Anim Sci (2011) 1.08
Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci (1996) 1.06
Genetic and environmental factors associated with incidence of infectious bovine keratoconjunctivitis in preweaned beef calves. J Anim Sci (2005) 1.06
Herniated cerebellar tonsils and cough syncope. J Neurosurg (1974) 1.05
Accuracy of genomic breeding values in multibreed beef cattle populations derived from deregressed breeding values and phenotypes. J Anim Sci (2012) 1.04
Expected relative responses to selection for alternative measures of life cycle economic efficiency of pork production. J Anim Sci (1983) 1.03
Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum (1996) 1.01
Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution. Structure (1998) 1.01
Identification and characterization of SPRK, a novel src-homology 3 domain-containing proline-rich kinase with serine/threonine kinase activity. J Biol Chem (1994) 1.00
Ligand-regulated nonspecific inactivation of receptor function: a versatile mechanism for signal transduction. Cold Spring Harb Symp Quant Biol (1988) 0.99
Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin. J Cell Biol (1983) 0.98
Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. Oncogene (1992) 0.98
Urokinase binding sites on human foreskin cells. Evidence for occupancy with endogenous urokinase. Biochem Biophys Res Commun (1985) 0.98
Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1. J Biol Chem (1993) 0.98
Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain. J Biol Chem (1997) 0.97
Serum-stimulated release of cell contacts and the initiation of growth in contact-inhibited chick fibroblasts. Proc Natl Acad Sci U S A (1971) 0.96
Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins. Effects of mutations in the potential proteolytic cleavage site on processing and ligand binding. J Biol Chem (1992) 0.96
Interleukin-8: a review. Cancer Invest (1993) 0.96
Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor. Protein Eng (1994) 0.96
Assessment of single nucleotide polymorphisms in genes residing on chromosomes 14 and 29 for association with carcass composition traits in Bos indicus cattle. J Anim Sci (2005) 0.95